Aurobindo Pharma informs about press release
Aurobindo Pharma has enclosed a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities, a wholly owned subsidiary of the Company, for Everolimus Tablets, 0.25 mg, 0.5 mg, 0.75 mg and 1 mg.
The above information is a part of company’s filings submitted to BSE.
